Insight Molecular Diagnostics Inc.
Company Information
Industry In Vitro & In Vivo Diagnostic Substances
SIC Code 2835
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation CA
Business Address 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
Mailing Address 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
Phone 949-409-7600
Fiscal Year End 1231
EIN 271041563
Financial Overview
FY2024
$34.29M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | February 12, 2026 | View on SEC |
| 8-K Current report of material events | February 12, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | February 12, 2026 | View on SEC |
| 8-K Current report of material events | February 11, 2026 | View on SEC |
| 424B5 Prospectus supplement | February 11, 2026 | View on SEC |
| 4/A Insider transaction amendment | November 13, 2025 | View on SEC |
| 8-K Current report of material events | November 10, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 10, 2025 | View on SEC |
| 4 Insider stock transaction report | November 4, 2025 | View on SEC |
| 8-K Current report of material events | October 2, 2025 | View on SEC |
Insider Trading
BUY 1 insiders
2 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2835)
QuidelOrtho Corp
QDEL In Vitro & In Vivo Diagnostic Substances
IDEXX LABORATORIES INC /DE
IDXX In Vitro & In Vivo Diagnostic Substances
VOLITIONRX LTD
VNRX In Vitro & In Vivo Diagnostic Substances
NEOGEN CORP
NEOG In Vitro & In Vivo Diagnostic Substances
Intellia Therapeutics, Inc.
NTLA In Vitro & In Vivo Diagnostic Substances
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.